Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction.
about
Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposureChronic amiodarone therapy impairs the function of the superior sinoatrial node in patients with atrial fibrillation.Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockersThe influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, CanadaFunction and dysfunction of human sinoatrial nodeOverview of the management of atrial fibrillation: what is the current state of the art?Atrial fibrillation in heart failure: prognostic significance and management.Risk factors for bradycardia requiring pacemaker implantation in patients with atrial fibrillation.Pharmacotherapy changes following pacemaker implantation in patients with bradycardia-tachycardia syndrome.Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation.Sex differences in response to chronic heart failure therapies.Prognosis and natural history of drug-related bradycardia.Chinese medicine shensongyangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trialAtrial fibrillation and heart failure in the elderly.Effect of amiodarone dose on the risk of permanent pacemaker insertion.Arrhythmias in the coronary care unit.Economic burden and disparities in healthcare resource use among adult patients with cardiac arrhythmia.Acute Sinus Node Dysfunction after Atrial Ablation: Incidence, Risk Factors, and Management.Drug induced bradycardia: to pace or not to pace?[Clinical aspects of treatment with amiodarone].Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.
P2860
Q24799850-C37E42A0-1344-416B-BA4F-CEC3690AC27EQ34063761-441E07D7-1935-45EF-B963-0FEC3A78048AQ35110915-84FAE4EF-3F42-433C-97AE-CD32F1EF7EE1Q35568937-8F2E3E9E-6AFF-4BD7-9E8E-4CA811428F5DQ35658401-8A9731CD-DC92-4B43-9143-350ABBADEF2AQ35684050-9F3D4774-1032-48E2-B439-3466AE84464BQ35684055-48D56912-B768-4BB4-9FD9-B9D91FB33C5FQ36315573-75D7F739-613D-4835-9ABE-882AAB422723Q36632222-67196358-6B4C-4230-A98A-72D1D8F8F40CQ36713626-0BBD400F-B183-4A2A-93F1-6D80CDC16163Q37134506-62AC9FEB-57E0-4B57-87D4-874CDA887000Q37408756-92489954-9A42-4A4A-9C49-AE8C13DB021CQ37556513-6C3A8CE7-4C58-4313-975D-82953FA0E024Q37952604-EA42751C-DF9C-44C4-BAE4-9C01A13D9DF2Q45152243-EFE22C6E-7537-4E2B-9237-66A617B2A587Q46549329-15134F65-FF90-4157-BB4E-7793BCE3689EQ46830286-11C3DE89-6788-4558-88DC-288A19FCC2D3Q51197718-B43C63B6-F092-41FC-944D-4D7189E52DCCQ51632759-9A8B5CB3-000D-4540-B15F-222C7EBA7400Q52597049-E4086BF3-09D6-40C7-B613-2C95986A9D2EQ54975902-AE920490-E315-4BE8-B4EA-1B12B0D24794
P2860
Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Amiodarone and the risk of bra ...... d prior myocardial infarction.
@en
Amiodarone and the risk of bra ...... d prior myocardial infarction.
@nl
type
label
Amiodarone and the risk of bra ...... d prior myocardial infarction.
@en
Amiodarone and the risk of bra ...... d prior myocardial infarction.
@nl
prefLabel
Amiodarone and the risk of bra ...... d prior myocardial infarction.
@en
Amiodarone and the risk of bra ...... d prior myocardial infarction.
@nl
P1476
Amiodarone and the risk of bra ...... d prior myocardial infarction.
@en
P2093
Tom Hadjis
Vidal Essebag
P304
P356
10.1016/S0735-1097(02)02709-2
P407
P577
2003-01-01T00:00:00Z